Abstract
Marinobufagenin (MBG) is an endogenous Na/K-ATPase inhibitor, a natriuretic and a vasoconstrictor. MBG is implicated in salt-sensitive hypertension, cardiac hypertrophy, and initiate the pro-fibrotic signaling. Previously it was demonstrated that immunoneutralization of an endogenous MBG by 3E9 anti-MBG-antibody (mAb) in vivo lowered blood pressure (BP) and reversed cardiac fibrosis in salt-sensitive, and in partially nephrectomized rats. In the present study, we investigated whether mAb alleviates vascular remodeling induced in normotensive rats on high salt intake. Wistar rats (5 months old) received normal (CTRL; n = 8) or high salt intake (2% NaCl in drinking water) for 4 weeks ( n = 16). Rats from the group on a high salt intake were administered vehicle (SALT; n = 8) or mAb (50 µg/kg) (SALT-AB; n = 8) during the last week of high salt diet. BP, erythrocyte Na/K-ATPase activity, levels of MBG in plasma and 24-hour urine, and sensitivity of aortic explants to the vasorelaxant effect of sodium nitroprusside (SNP) were measured. Aortic collagen abundance was determined immunohistochemically. In SALT vs. CTRL, heightened levels of MBG were associated with inhibition of erythrocyte Na/K-ATPase in the absence of BP changes. High...Continue Reading
References
May 1, 1977·The American Journal of Physiology·M P Blaustein
Jun 19, 2001·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·O V FedorovaA Y Bagrov
Mar 6, 2002·Circulation·Olga V FedorovaAlexei Y Bagrov
Apr 13, 2004·Journal of Hypertension·Olga V FedorovaAlexei Y Bagrov
Mar 19, 2005·Journal of Hypertension·Olga V FedorovaAlexei Y Bagrov
Jul 9, 2005·Journal of Hypertension·Olga V FedorovaAlexei Y Bagrov
Dec 6, 2006·Hypertension·Jihad ElkarehJoseph I Shapiro
Jun 17, 2008·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Wilhelm Schoner, Georgios Scheiner-Bobis
Aug 1, 2008·Journal of the American Society of Nephrology : JASN·Elizabeth L LoreauxJerry B Lingrel
Nov 15, 2008·Journal of Hypertension·Olga V FedorovaAlexei Y Bagrov
Mar 6, 2009·American Journal of Physiology. Renal Physiology·Jihad ElkarehJoseph I Shapiro
Mar 28, 2009·Pharmacological Reviews·Alexei Y BagrovOlga V Fedorova
Nov 17, 2009·Life Sciences·Ariel Jaitovich, Alejandro M Bertorello
Feb 13, 2010·Annual Review of Physiology·Jerry B Lingrel
Sep 21, 2010·Biochimica Et Biophysica Acta·Mohammad N UddinJules B Puschett
Feb 19, 2011·Journal of Hypertension·Elena R NikitinaAlexei Y Bagrov
Feb 25, 2011·Journal of Hypertension·Dinko SusicL Gabriel Navar
May 20, 2011·American Journal of Physiology. Renal Physiology·Nadezda KoleganovaMarie-Luise Gross-Weissmann
Mar 2, 2012·American Journal of Hypertension·Steven T HallerAlexei Y Bagrov
Mar 28, 2012·The Journal of Biological Chemistry·Changxuan LiuJiang Tian
Jun 5, 2012·Journal of Inorganic Biochemistry·M PuckeridgeP W Kuchel
Dec 11, 2013·IUBMB Life·Jeffrey X XieZijian Xie
Dec 12, 2013·Obstetrics & Gynecology Science·Young Ju Kim
Aug 15, 2014·The Journal of Nutrition·Isis A KatayamaJoel C Heimann
Mar 24, 2015·PloS One·Yuka HayakawaShinya Minatoguchi
Jul 3, 2015·Journal of Hypertension·Olga V FedorovaAlexei Y Bagrov
Citations
Mar 1, 2019·PloS One·Martin H KeppelStefan Pilz
Jun 20, 2017·Current Medicinal Chemistry·Sergei N OrlovNickolai O Dulin
Aug 16, 2019·Journal of Cardiovascular Pharmacology·Olga V FedorovaAlexei Y Bagrov
Mar 17, 2020·Hypertension·Keneilwe N MmopiAngela J Woodiwiss
Oct 18, 2018·International Journal of Molecular Sciences·Yulia N GrigorovaOlga V Fedorova
Feb 2, 2019·International Journal of Molecular Sciences·Aneta PaczulaGrzegorz Piecha
Sep 12, 2018·International Journal of Molecular Sciences·Fatimah K KhalafDavid J Kennedy
Oct 3, 2019·Journal of the American Heart Association·Yongqing ZhangOlga V Fedorova
Aug 28, 2021·Life·Natalia Słabiak-Błaż, Grzegorz Piecha
Sep 30, 2021·Canadian Journal of Physiology and Pharmacology·Himanshu SankrityayanAnil Bhanudas Gaikwad